Thomas Hallam - 17 Feb 2022 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Role
Chief Executive Officer, Director
Signature
/s/ JD Finley, Attorney-in-Fact for Thomas Hallam
Issuer symbol
PALI
Transactions as of
17 Feb 2022
Net transactions value
$0
Form type
4
Filing time
22 Feb 2022, 16:58:23 UTC
Previous filing
10 Feb 2022
Next filing
29 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PALI Stock Option (right to buy) Award $0 +156,600 $0.000000 156,600 17 Feb 2022 Common Stock 156,600 $0.9500 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/12th of the shares underlying the Stock Option shall vest and become exercisable on each three-month anniversary of the vesting commencement date and if there is no corresponding day, the last day of the month.